$163.13
1.410.87%
At close: -
$163.40
0.270.17%
After Hours: 6:07 PM EDT
Comments
Loading...
Latest Johnson & Johnson Stock News | NYSE:JNJ | Benzinga
Get the latest news on Johnson & Johnson stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Johnson & Johnson performance
Categories: All
Wednesday, March 26, 2025
Friday, March 21, 2025
- Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
- FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
- Johnson & Johnson To Invest $55 Billion In US To Boost Manufacturing, Drug Discovery
- Johnson & Johnson Plans Manufacturing, R&D An...
- Reported Earlier, FDA Approves Johnson & John...
Thursday, March 20, 2025
Tuesday, March 18, 2025
- Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
- FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
- Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding Burden
- Johnson & Johnson Announces That The U.S. FDA...
Sunday, March 16, 2025
Saturday, March 15, 2025
Wednesday, March 12, 2025
Tuesday, March 11, 2025
Monday, March 10, 2025
- How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket
- Guggenheim Reiterates Neutral on Johnson & Jo...
- Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
- CORRECTION: Genmab shares are trading lower a...
- Genmab Announces Johnson & Johnson Has Decide...
- Why Is Protagonist Therapeutics Stock Trading Higher On Monday?
- Johnson & Johnson Announces Health Canada Aut...
- Johnson & Johnson Announces Icotrokinra Meets...
- Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
- Reported Saturday, Johnson & Johnson's Icotro...